The technology was able to detect about 20% more cancers when compared to standard screening, without impacting false positives.

Breast radiologists are known to have higher rates of burnout in comparison to many of their peers, but the beginning of the pandemic brought this group something not often encountered within the specialty—downtime. 

"This system is bringing with it a greater humanization of AI and therefore a more realistic representation of what we do as radiologists,” one member of the specialty said. 

ICAD Inc. said the deal spans multiple years and will see the nation’s largest radiology group adopting its breast  technology across the enterprise.

Scientists see important implications from their work as practice leaders seek to improve efficiency and the patient experience. 

It’s also the fifth local legislature to do so in 2023, following in the footsteps of Tennessee, Washington, Maryland and New Mexico. 

The findings were reached using an analytic hierarchy process, which can help physicians review options with patients who have never experienced either exam.

The Germany-based corporation said this is the “only contrast agent approved for this indication” in America.